News Features Holding Out Hope for HF Shunts, Even After an FDA Panel’s Doubts Michael O'Riordan February 24, 2026
News Features Cardiac Transplant in Midst of ‘Revolution,’ but Public Trust Is Fragile Michael O'Riordan October 17, 2025
News Features ‘Buzz and Discussion’ Driving Return to In-Person Cardiology Meetings Michael O'Riordan September 17, 2025
News Features AEDs, Like Fire Extinguishers, Should Be in Every School, Say Experts Michael O'Riordan February 19, 2025
News Features Weight-Loss Showdown: Is It Time for an RCT of Bariatric Surgery vs GLP-1s? Michael O'Riordan January 17, 2025
News Features Can ‘Body Roundness Index’ Replace BMI? That Depends, Say Experts Michael O'Riordan October 21, 2024
News Features Let’s Talk About Sex: How Best to Broach Post-MI Conversations Caitlin E. Cox June 14, 2024
News Features The Promise of Pulsed-Field Ablation: Cautious Optimism Amid Some Unknowns Todd Neale March 29, 2024
News Features Going Solo: Can TAVI Be Performed Without a Surgical Safety Net? Michael O'Riordan January 22, 2024
News Features Chaos and Questions: New Public-Access Policies Put Journals in Flux Michael O'Riordan August 14, 2023
News Features Skyrocketing Popularity Puts GLP-1 Agonists for Weight Loss on Cardiology’s Radar L.A. McKeown May 12, 2023
News Features As Violent Attacks on Healthcare Workers Rise, Cardiology Takes Note Shelley Wood January 27, 2023
News Features Major TAVI Studies Have ‘Methodological Issues,’ INTEGRITTY Group Contends Michael O'Riordan January 06, 2023
News Features Does BEST-CLI Settle the Surgery vs Endovascular Question for CLTI? L.A. McKeown December 02, 2022
News Features Novel Targets, Gene Edits, and Vaccines: Is a ‘Golden Era’ Dawning for ASCVD? Michael O'Riordan August 15, 2022
News Features TVT 2022 Minorities, Poorer Patients Missing Out on Structural Heart Care Michael O'Riordan June 15, 2022
News Features Realistic Expectations Emerge After Initial Excitement Over Xenotransplant Yael L. Maxwell January 21, 2022
News Features Pricey Inclisiran Is Rolling Out: a ‘Buy-and-Bill’ Model May Smooth Its Path Michael O'Riordan January 17, 2022
News Features FFR’s Future: Negative Trials Spur Debate Over Technology’s Role Michael O'Riordan December 23, 2021